Piritta Maunu – Appointment Announcement

02.03.2026

Piritta Maunu, M.Sc. in Cell Biology, will start in her new role as Regulatory Affairs and Product Safety Director on 2 March 2026. Piritta brings more than 20 years of experience in regulatory and quality roles from organizations such as Pharmalex Finland / Cencora and SGS Fimko.

At Galena Pharma we are pleased to welcome Piritta to strengthen our regulatory and product safety function. She brings extensive expertise in regulatory compliance of medical devices and pharmaceuticals, quality management, and authority interactions — all essential capabilities as we continue to grow internationally.

She will report directly to the CEO.

“We are delighted to welcome Piritta to our highly skilled Galena team. Her long-standing experience in regulatory affairs and product safety will further reinforce our position in the rapidly evolving international markets”, says CEO Alexej von Bagh.

Galena Pharma is a GMP- and EU MDR–certified pharmaceutical company specializing in manufacturing and developing substance‑based medical devices. Galena Pharma provides its own ready‑to‑market MDR‑approved medical devices for in‑licensing as private label products. Our key focus areas include gastrointestinal health, female intimate care, cough & cold, pain, and skin care.

Galena Pharma is a GMP- and EU MDR -certified pharmaceutical company specializing in manufacturing and developing substance-based medical devices. Galena Pharma provides its own ready-to-market MDR-approved medical devices for in-licensing as private label products. Our focus indication areas are gastrointestinal, female intimate care, cough & cold, pain and skin care.